Long-term follow-up studies are essential for understanding the true impact of interventional treatments like CAR T, but too often, the patient experience makes long-term participation nearly impossible.
In this recording from SCOPE Summit 2026, hear directly from Lindsay Guentzel, multimedia journalist and patient advocate, about her challenges participating in an interventional trial and her thoughts on the 15-year follow-up study. From slow reimbursements to last-minute scheduling changes, Lindsay's story exposes the friction points that drive patients away. Dan Drozd, CMO at PicnicHealth, shares how the industry can do better and ensure researchers get the data they need without burdening patients.
Watch this recording to hear a firsthand story of what's broken and the solutions available to fix it.